Focus Surgery is a pioneer in the development and commercialization of products using High Intensity Focused Ultrasound - HIFU - for the treatment of prostate diseases.

Based in Indianapolis, Indiana, Focus Surgery designs and manufactures the Sonablate^® 500 system, an image-guided acoustic ablation device. Doctors worldwide have already successfully treated thousands of prostate cancer and BPH patients using the Sonablate^® 500.
 

Focus Surgery maintains an internationally accredited Quality System which has achieved ISO 9001-2000 and ISO 13485-2003 certifications.  The  Sonablate^® 500 has the CE Mark for the treatment of prostate diseases in Europe and MHW approval in Japan.  The Sonablate^® 500 is approved by the FDA as an investigational device for clinical trials in the United States.

The company has developed an extensive intellectual property portfolio with approved and pending patent applications, as well as partnerships with the leading clinical and scientific researchers from around the world.  This research ensures that Focus Surgery will maintain it's  position at the forefront of HIFU technology.

Focus Surgery and its employees are dedicated to improving the quality of care to patients with localized or recurrent prostate disease, both benign and cancerous.

If you would like additional information on Focus Surgery please feel free to contact us.

The Sonablate^® 500 is an investigational device limited by Federal Law to investigational use in the United States.

Send mail to focus@focus-surgery.com with questions or comments about this web site.
Copyright © 2004-2007